Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 16, Issue 8, 2010, Pages 1393-1396

  Cury, Dídia Bismara ^a   Moss, Alan C ^b  

^a Center of Bowel Inflammatory Diseases   (Brazil)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

5 ASA use; IBD; Ocular manifestations

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MESALAZINE; METHOTREXATE; STEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; BLEPHARITIS; BLURRED VISION; CATARACT; COHORT ANALYSIS; CONJUNCTIVITIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRY EYE; ENTEROPATHY; EPISCLERITIS; EYE BURNING; EYE DISEASE; FEMALE; GENDER; HUMAN; LACRIMAL GLAND FUNCTION; MAJOR CLINICAL STUDY; MALE; NEURITIS; OCULAR PRURITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCLERITIS; SLIT LAMP; ULCERATIVE COLITIS; UVEITIS; VASCULITIS; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

ACUTE DISEASE; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; COHORT STUDIES; CYCLOSPORINE; DRY EYE SYNDROMES; EYE DISEASES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MESALAMINE; METHOTREXATE; MIDDLE AGED; STEROIDS; TREATMENT OUTCOME;

EID: 77955747990     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21180     Document Type: Article

References (18)

1. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116-1122. (Pubitemid 32319146)
2. Knox DL, Schachat AP, Mustonen E. Primary, secondary and coincidental ocular complications of Crohn's disease. Ophthalmology. 1984;91:163-173. (Pubitemid 14193858)
3. Petrelli EA, McKinley M, Troncale FJ.Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol. 1982;14:356-360. (Pubitemid 12119365)
4. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55:401-412.
5. Hopkins DJ, Horan E, Burton IL, et al. Ocular disorders in a series of 332 patients with Crohn's disease. Br J Ophthalmol. 1974;58:732-737.
6. Yilmaz S, Aydemir E, Maden A, et al. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis. 2007;22:1027-1030. (Pubitemid 47500243)
7. Felekis T, Katsanos K, Kitsanou M, et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis. 2009;15:29-34.
8. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
9. Miner P. Clinical features, course, laboratory findings, and complications in ulcerative colitis. In: Kirsner J, ed. Inflammatory Bowel Disease. Chicago: W.B. Saunders; 2000:299-304.
10. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82:10-14.
11. Cho P, Yap M. Schirmer test. I. A review. Optom Vis Sci. 1993;70:152-156.
12. Paschides CA, Kitsios G, Karakostas KX, et al. Evaluation of tear break-up time, Schirmer's-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol. 1989;7:155-157.
13. Jackson WB. Management of dysfunctional tear syndrome: a Canadian consensus. Can J Ophthalmol. 2009;44:385-394.
14. Lanna CC, Ferrari Mde L, Rocha SL, et al. A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol. 2008;27:503-509.
15. Palm O, Moum B, Gran JT. Estimation of Sjogren's syndrome among IBD patients. A six year post-diagnostic prevalence study. Scand J Rheumatol. 2002;31:140-145. (Pubitemid 34713077)
16. Hwang IP, Jordan DR, Acharya V. Lacrimal gland inflammation as the presenting sign of Crohn's disease. Can J Ophthalmol. 2001;36:212-213. (Pubitemid 32634588)
17. Piper H, Douglas KM, Treharne GJ, Mitton DL, Haider S, Kitas GD. Prevalence and predictors of ocular manifestations of RA: is there a need for routine screening? Musculoskelet Care. 2007;5:102-117.
18. Barnett KC, Joseph EC. Keratoconjunctivitis sicca in the dog following 5-aminosalicylic acid administration. Hum Toxicol. 1987;6:377-383.